3 ms·
The last time I was working with molecular modeling, proteins were still the main target. With the advent of cryoEM, glycobiology of proteins can now be discern
by text70 6y ago
The last time I was working with molecular modeling, proteins were still the main target. With the advent of cryoEM, glycobiology of proteins can now be discerned. Now, AI is starting to be able to predict entire secondary structures from sequence alone. It will take massive computational power, but I can see how toxicology may soon be able to be predicted from in silico experiments.
- ramraj07 6y agoThe point of this post (and what I realised during my PhD) was that for the most part this doesn’t matter; choice of targets and predicting the human efficacy of a therapy that works in a tube or mice is far more important and typically more ignored. People don’t focus on that because it’s a hard problem especially for math and computer people who think their absence is the reason cancer isn’t cured yet and come over to try and win the Nobel prize (and don’t; cue relevant xkcd).